This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Nevada Transgenic Center is the first and only mouse transgenic facility in the state of Nevada. The objective of this Core is to make transgenic technology available to investigators who are not trained in the technical details of mammalian embryo manipulation, embryonic stem cell culture, animal breeding or microinjection. The Nevada Transgenic Center has successfully produced mice lacking the chloride ion channel ClC-3, alpha7 integrin chain and testis specific Bax-like protein, BAT1. In addition,? mice over-expressing the long and short isoforms of the chloride ion channel ClC-3 in the heart have been produced. Technology to generate tissue-specific (cre/lox) or inducible (tetracycline) knockout mice for ClC-3 and the potassium ion channel TREK1 are currently being employed within the Transgenic Core. The Transgenic Core consists of three components. First, an embryonic stem cell facility provides a complete mouse embryonic stem cell culture and gene targeting services. Second, a microinjection facility performs pronuclear and blastocyst injections. Third, an animal service provides mice and embryos for the core researchers, performs embryo transfers, and has the responsibility for managing transgenic mouse lines and colonies. In addition, core personnel oversee breeding programs for transgenic mice used by COBRE investigators. In this next funding period, mice over-expressing or lacking cardiac chloride channels (e.g. ClC-2, Bestrophin), cardiac integrin chains (beta1 and alpha7 integrin) and regulatory proteins (Receptor for Activated C Kinase (RACK1) and Serum/Glucocorticoid regulated Kinase (SGK)) will be generated by the Transgenic Core for COBRE investigators. Generation of these genetically modified mice will provide a valuable resource to allow COBRE investigators to continue to study the pathophysiological consequences of altered chloride channel activity on cardiac function.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015581-10
Application #
7959484
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2009-06-01
Project End
2010-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
10
Fiscal Year
2009
Total Cost
$325,145
Indirect Cost
Name
University of Nevada Reno
Department
Pharmacology
Type
Schools of Medicine
DUNS #
146515460
City
Reno
State
NV
Country
United States
Zip Code
89557
Ba, Mariam A; Surina, Jeffrey; Singer, Cherie A et al. (2017) Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway. BMC Pharmacol Toxicol 18:47
Duan, Dayue Darrel (2013) Phenomics of cardiac chloride channels. Compr Physiol 3:667-92
Forrest, Abigail S; Joyce, Talia C; Huebner, Marissa L et al. (2012) Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension. Am J Physiol Cell Physiol 303:C1229-43
von Bartheld, Christopher S (2012) Distribution of Particles in the Z-axis of Tissue Sections: Relevance for Counting Methods. Neuroquantology 10:66-75
Angermann, Jeff E; Forrest, Abigail S; Greenwood, Iain A et al. (2012) Activation of Ca2+-activated Cl- channels by store-operated Ca2+ entry in arterial smooth muscle cells does not require reverse-mode Na+/Ca2+ exchange. Can J Physiol Pharmacol 90:903-21
Li, Chuanwei; Pei, Fang; Zhu, Xiaoshan et al. (2012) Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45:727-32
Wiggins, Larisa M; Kuta, A; Stevens, James C et al. (2012) A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons. J Comp Neurol 520:2757-73
Duan, Dayue Darrel (2011) The ClC-3 chloride channels in cardiovascular disease. Acta Pharmacol Sin 32:675-84
He, Xuyu; Gao, Xiuren; Peng, Longyun et al. (2011) Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 108:164-75
Xiang, Sunny Yang; Ye, Linda L; Duan, Li-lu Marie et al. (2011) Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury. Acta Pharmacol Sin 32:824-33

Showing the most recent 10 out of 77 publications